CTOs on the Move

Eyevance Pharmaceuticals

www.eyevance.com

 
EYEVANCE Pharmaceuticals` mission is to develop and commercialize INNOVATIVE and IMPACTFUL ophthalmic products to enable optimal vision and better quality of life for all patients
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.eyevance.com
  • 777 Taylor Street Suite 1050
    Fort Worth, TX USA 76102
  • Phone: 817.677.6120

Executives

Name Title Contact Details

Funding

Eyevance Pharmaceuticals raised $30M on 11/01/2019

Similar Companies

Douglas Laboratories

Douglas Laboratories is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Anne Arundel Dermatology

With modern, attractive clinical offices in Annapolis, Glen Burnie, Hagerstown, Prince Frederick, Leonardtown, Kent Island, and Easton, 19 board certified physicians, 7 physician assistants, 2 certified nurse practitioners, a full service cosmetic lase...

Opko

OPKO Health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. Our diagnostics business includes BioReference Laboratories, the nation`s third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros® 1 in office immunoassay platform. Our pharmaceutical business features RAYALDEE, an FDA approved treatment for SHPT in stage 3-¬4 CKD patients with vitamin D insufficiency (launched in November 2016), VARUBITM for chemotherapy induced nausea and vomiting (oral formulation launched by partner TESARO and IV formulation pending FDA approval), OPK88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in Phase 2 clinical trials, among the new class of GLP-¬1 glucagon receptor dual agonists, and OPK88003, a selective androgen receptor modulator for benign prostatic hyperplasia (Phase 2). Our biologics business includes hGH-¬CTP, a once weekly human growth hormone in Phase 3 and partnered with Pfizer; and a long-¬acting Factor VIIa drug for hemophilia in Phase 2a.

Synergy Health Partners

Synergy Health Partners is the car accident doctor you can trust. We offer chiropractic treatment, physical therapy, and massages.

DK Sinopharma

DK Sinopharma is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.